We found that inhibiting miR-34a in PC3 as well as the Ras signaling-activated prostate cancer cell line, RasB1, was accompanied by an increase in TCF7, indicating that TCF7 is a candidate target gene for miR-34a (Figure 3A). Here, TCF7 is linked to prostate cancer.